<DOC>
	<DOCNO>NCT00311376</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness botulinum toxin type A treat overactive bladder spinal cord injury multiple sclerosis patient .</brief_summary>
	<brief_title>Safety Efficacy Study Botulinum Toxin Type A Treatment Neurogenic Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Urinary incontinence result neurogenic overactive bladder due spinal cord injury multiple sclerosis Inadequate response anticholinergic medication use treat overactive bladder History evidence pelvic urologic abnormality Previous current diagnosis bladder prostate cancer Urinary tract infection time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>